FR2540121B1 - Procede de preparation d'un facteur stimulant des colonies et de kallikreine provenant de l'urine humaine - Google Patents

Procede de preparation d'un facteur stimulant des colonies et de kallikreine provenant de l'urine humaine

Info

Publication number
FR2540121B1
FR2540121B1 FR8401202A FR8401202A FR2540121B1 FR 2540121 B1 FR2540121 B1 FR 2540121B1 FR 8401202 A FR8401202 A FR 8401202A FR 8401202 A FR8401202 A FR 8401202A FR 2540121 B1 FR2540121 B1 FR 2540121B1
Authority
FR
France
Prior art keywords
kallikrein
preparation
stimulating factor
colony stimulating
human urine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8401202A
Other languages
English (en)
Other versions
FR2540121A1 (fr
Inventor
Satoshi Funakoshi
Kazuo Morimoto
Morio Kuboyama
Nobuya Yanai
Muneo Yamada
Hajime Yokota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Publication of FR2540121A1 publication Critical patent/FR2540121A1/fr
Application granted granted Critical
Publication of FR2540121B1 publication Critical patent/FR2540121B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/834—Urine; urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
FR8401202A 1983-01-28 1984-01-26 Procede de preparation d'un facteur stimulant des colonies et de kallikreine provenant de l'urine humaine Expired FR2540121B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58011317A JPS59137417A (ja) 1983-01-28 1983-01-28 人尿由来コロニ−形成刺激因子及びカリクレインの製造法

Publications (2)

Publication Number Publication Date
FR2540121A1 FR2540121A1 (fr) 1984-08-03
FR2540121B1 true FR2540121B1 (fr) 1987-09-04

Family

ID=11774637

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8401202A Expired FR2540121B1 (fr) 1983-01-28 1984-01-26 Procede de preparation d'un facteur stimulant des colonies et de kallikreine provenant de l'urine humaine

Country Status (7)

Country Link
US (1) US4482485A (fr)
JP (1) JPS59137417A (fr)
AU (1) AU545411B2 (fr)
CA (1) CA1200489A (fr)
DE (1) DE3402647C2 (fr)
FR (1) FR2540121B1 (fr)
GB (1) GB2134528B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146851A (en) * 1985-02-05 2000-11-14 Chiron Corporation DNA encoding NV2 (long form) and carboxy truncated fragments thereof
US5792450A (en) * 1985-02-05 1998-08-11 Chiron Corporation Purified human CSF-1
US5422105A (en) * 1985-02-05 1995-06-06 Cetus Oncology Corporation Use of recombinant colony stimulating factor 1
US5104650A (en) * 1985-02-05 1992-04-14 Cetus Corporation Uses of recombinant colony stimulating factor-1
WO1986004607A1 (fr) * 1985-02-05 1986-08-14 Cetus Corporation Facteur-1 recombinant stimulant la formation de colonies
US5573930A (en) 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
US6156300A (en) * 1985-02-05 2000-12-05 Chiron Corporation Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
US5837229A (en) * 1985-02-05 1998-11-17 Chiron Corporation Uses of recombinant colony stimulating factor-1
US4847201A (en) * 1985-02-05 1989-07-11 Cetus Corporation DNA encoding for CSF-1 and accompanying recombinant systems
WO1986004587A1 (fr) * 1985-02-05 1986-08-14 Cetus Corporation Purification du facteur-1 de stimulation de colonies naturelles
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
JPH0753667B2 (ja) * 1985-08-09 1995-06-07 新技術開発事業団 骨髄移植療法補助剤
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
JPH0618779B2 (ja) * 1986-01-22 1994-03-16 中外製薬株式会社 造血機能回復促進剤
AU605901B2 (en) * 1987-09-11 1991-01-24 Ares Trading S.A. Purification process
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
JPH05163158A (ja) * 1991-12-13 1993-06-29 Sanwa Kagaku Kenkyusho Co Ltd 人尿性キニノゲナーゼを有効成分とする皮膚潰瘍の予防及び治療剤
US5695928A (en) * 1993-12-10 1997-12-09 Novartis Corporation Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction
US20030212021A1 (en) * 2001-01-25 2003-11-13 Frost Gregory I. Myeloid colony stimulating factor and uses thereof
JP3872003B2 (ja) 2002-10-22 2007-01-24 竹内精工株式会社 ボールリニアガイド及びボールリニアガイドの製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2874088A (en) * 1952-08-25 1959-02-17 Bayer Ag Recovery of kallikrein
DE1102973B (de) * 1960-03-25 1961-03-23 Bayer Ag Verfahren zur Herstellung von hoch gereinigten Kallikrein-Praeparaten
BE790794A (fr) * 1971-11-03 1973-04-30 Bayer Ag Procede de purification et de cristallisation de kallicreine
US3905870A (en) * 1972-11-03 1975-09-16 Bayer Ag Purification of kallikrein
JPS5544726B2 (fr) * 1973-05-17 1980-11-13
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
JPS5517364A (en) * 1978-07-25 1980-02-06 Toho Yakuhin Kogyo Kk Purification of pancreatic kallikrein
IN150740B (fr) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4178285A (en) * 1978-12-20 1979-12-11 Felts James M Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system
US4342828A (en) * 1979-07-20 1982-08-03 Morinaga Milk Industry Co., Ltd. Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells
JPS5758629A (en) * 1980-09-25 1982-04-08 Morinaga Milk Ind Co Ltd Separating and purifying method of colonization stimulating factor and callicrein in human urine
DE3103257A1 (de) * 1981-01-31 1982-08-26 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung des hochreinen enzyms kallikrein aus schweinepankreas-extrakten
US4359415A (en) * 1981-06-03 1982-11-16 University Of Tennessee Research Corporation Isolation of an antineoplastic protein fraction and an antineoplastic peptide fraction from human urine

Also Published As

Publication number Publication date
DE3402647A1 (de) 1984-08-02
GB8334220D0 (en) 1984-02-01
GB2134528A (en) 1984-08-15
AU545411B2 (en) 1985-07-11
GB2134528B (en) 1986-08-20
FR2540121A1 (fr) 1984-08-03
JPS6160049B2 (fr) 1986-12-19
US4482485A (en) 1984-11-13
AU2280683A (en) 1984-08-02
DE3402647C2 (de) 1986-11-27
CA1200489A (fr) 1986-02-11
JPS59137417A (ja) 1984-08-07

Similar Documents

Publication Publication Date Title
FR2540121B1 (fr) Procede de preparation d'un facteur stimulant des colonies et de kallikreine provenant de l'urine humaine
GB2092159B (en) Process for the production of human colony stimulating factor
FR2617488B1 (fr) Procede de fabrication de structures organisees de collagene, notamment d'origine humaine, et structures organisees de collagene correspondantes
FR2545100B1 (fr) Procede d'obtention de cultures d'hepatocytes humains, les cultures obtenues et leurs applications biologiques et biochimiques
MC1998A1 (fr) Composes pour le traitement des maladies hyperproliferatibes et procede de preparation
BE895961A (fr) Procede de preparation d'un clone bacterien produisant de 1'alpha 1-antitrypsine humaine
FR2564114B1 (fr) Procede et appareil pour le traitement a sec d'un tissu
FR2563208B1 (fr) Procede de traitement des eaux par l'ozone
NO925048L (no) Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet
MA21981A1 (fr) Procede de vieillissement accelere et de traitement des rhyzomes d'iris .
ZA898818B (en) Biological treatment of waste water
FR2630099B1 (fr) Procede de traitement et de purification d'eaux
LTIP1750A (en) Method for biological treatment of waste water
GB2263905B (en) Treatment of waste animal materials
FR2620439B1 (fr) Procede et dispositif de traitement par fermentation methanique d'eaux residuaires lipidiques
FR2605184B1 (fr) Nouveau micro-organisme et procede de culture l'utilisant
JPS57129893A (en) Treatment of waste fish
BE887828A (fr) Reactif et procede de dosage de l'aldolase musculaire humaine
PT85229A (fr) Procede de preparation des variants de l:alpha-antitrysine humaine glycosylee et vecteurs viral d:expression de l:alpha1-at
FR2565983B1 (fr) Derives de l'a1-antitrypsine humaine et procede pour leur preparation
IL66974A (en) Composition comprising a biologically pure culture of micrococcus pseudoflaccidifex and its use for biological control of insects
RO88062A2 (fr) Source controlee de diffusion de zn et procede d'obtention
RO80829A2 (fr) Medicament destine au traitement des cardiiopathies isquimiques et procede d'obtention
JPS553310A (en) Treatment of simultaneously evacuating and separating livestock excrements by photosynthetic bacteria and euglenas
GB8403850D0 (en) Biological treatment of waste water

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse